跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PIQRAY - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PIQRAY
Authorized
STANDARD
PIQRAY
novartis pharmaceuticals canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7054ec85726fcecd
Company
novartis pharmaceuticals canada inc
Type
Standard
Approval Details
Approval Id
7054ec85726fcecd
Drug Approval Canada Name
PIQRAY
Product Name
PIQRAY
Status
Marketed
Status Date
2020-06-29
Original Market Date
2020-06-29
Din
02497077
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01EM03 ALPELISIB
Atc Name
l 01 em 03
Aig Number
0162095003
Company Name
novartis pharmaceuticals canada inc
Company Address
100, 700 Rue Saint-Hubert, Montreal, Quebec, Canada, H2Y 0C1
Active Ingredients
ALPELISIB
200 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7054ec85726fcecd
Type
Standard
Back to Health Canada Approvals